Handelsavisen
prelaunch
RE
REVB.L London Stock Exchange Miscellaneous Specialty Retailers

Revolution Beauty Group PLC

$4,50
Open in Charts → Attach watcher ⌖
GBp
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
3,9B GBp
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Revolution Beauty Group PLC is a UK-based online beauty retailer that sells a range of beauty and personal care products, including makeup, skincare, and haircare, primarily through its e-commerce platform.

Business. Revolution Beauty Group PLC (REVB.L) is a miscellaneous specialty retailer headquartered in the United Kingdom and primarily listed on the London Stock Exchange. The company operates within the consumer cyclicals sector, generating revenue through the sale of beauty products. As specific operating segment and geographic breakdowns are not provided, the business is described at the industry level as a specialty retailer.

Classification92 %
SectorConsumer Cyclicals
Business sectorRetailers
IndustryMiscellaneous Specialty Retailers
ActivityRetailers
Generated · model-assisted
Sell-side consensus
HOLD1 analysts
0 buy1 hold0 sell
Avg 12m price target

Analyst recommendations

1 analysts · consensus Hold
Buy0
Hold1
Sell0
12-month price target
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
1 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning REVB.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary · THIS SECTOR+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to REVB.L. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Revolution Beauty Group PLC (REVB.L) is a miscellaneous specialty retailer headquartered in the United Kingdom and primarily listed on the London Stock Exchange. The company operates within the consumer cyclicals sector, generating revenue through the sale of beauty products. As specific operating segment and geographic breakdowns are not provided, the business is described at the industry level as a specialty retailer.

    Classification92 %
    SectorConsumer Cyclicals
    Business sectorRetailers
    IndustryMiscellaneous Specialty Retailers
    ActivityRetailers
    AI synthesis
    GENERATED

    Revolution Beauty has a market capitalization of £3.04 billion, with a market price of £3.50 per share, and no dilution risk as shares outstanding remain unchanged between basic and diluted counts. However, liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.

    Profitability remains a challenge, with the company reporting a loss of £0.02 per share in the latest period. This underperformance is consistent with the broader industry, where profitability is often constrained by high marketing and logistics costs. The company's revenue of £142.58 million reflects a competitive position in the online beauty retail space, though it trails the median for its industry.

    The company operates as a single business segment, with all revenue derived from its e-commerce platform. While this centralization simplifies operations, it also means that the company is highly exposed to shifts in consumer demand and digital platform performance.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction anticipated in the next fiscal year. This outlook is supported by the current revenue level and the absence of major catalysts or headwinds in the near term.

    Risk factors include the lack of liquidity visibility and the potential for regulatory or geopolitical shifts in the beauty retail sector. The company has not disclosed any dilution plans, and no recent events suggest a need for capital raising.

    Recent filings and transcripts have not revealed any material changes in strategy or operations. The company continues to focus on its core e-commerce model, with no new product lines or geographic expansions announced.

    Key takeaways
    • Revolution Beauty operates as a single-segment online beauty retailer with no disclosed geographic diversification.
    • The company reported a loss of £0.02 per share in the latest period, indicating ongoing profitability challenges.
    • Analysts have issued one "Hold" recommendation, with no "Buy" or "Strong Buy" ratings, suggesting limited upside potential.
    • No dilution risk is currently present, as shares outstanding remain unchanged between basic and diluted counts.
    • Revenue of £142.58 million places the company in a competitive but not dominant position within the beauty retail sector.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2025-08-22
    FY 2025 · Full-year highlights

    Revenue £142.6M, −25,5% YoY; Operating income −401,2% YoY.

    Revenue£142.6M−25,5 % YoY
    Operating income-£13.1M−401,2 % YoY
    Net income-£17.2M−261,1 % YoY
    Free cash flow-£18.7M−266,2 % YoY
    EPS
    Operating cash flow£8.6M+32,3 % YoY
    Financials
    Income statement
    Revenue£142.6M
    Gross profit£54.4M
    Operating income-£13.1M
    Net income-£17.2M
    Margins
    Gross margin38.2%
    Operating margin-9.2%
    Net margin-12.1%
    FCF margin-13.1%
    Balance sheet
    Total assets£81.0M
    Total liabilities£98.1M
    Total equity-£17.1M
    Cash & equivalents
    Long-term debt£33.2M
    Cash flow
    Operating cash flow£8.6M
    CapEx-£7.0M
    Free cash flow-£18.7M
    SBC
    P&L flow · revenue → net income
    Revenue £142.6MOperating costs £155.6MTax £4.2MNet income £17.2M
    Highlights
    • Revenue £142.6M, −25,5% YoY
    • Operating income −401,2% YoY
    • Net income −261,1% YoY
    • Free cash flow −266,2% YoY
    • Net margin -12.1%

    Valuation FY

    Market price
    $4,50
    Market cap
    $3.04B
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Corporate eventM&A horizon
    M&A probabilityconf 5 %
    Probability
    5 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-23 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-27

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy0
    Buy0
    Hold1
    Sell0
    Strong sell0

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    5 %
    Base rate
    3 %
    Band
    Moderate
    180-day horizon · target 2027-01-23 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Revolution Beauty Group PLC Market data — financials · 2026-05-29
    • Revolution Beauty Group PLC Market data — analyst estimates · 2026-05-29

    Ownership & reference

    Leadership

    • Lauren Elizabeth BrindleyChief Executive Officer, Executive Director

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $05 insiders · last 365d
    • Rolke JamesDirector, Chief Executive Officer · Common StockOther 10 115 @ $1,13$11K · 2026-04-30
    • Zygmont Chester Stanley IIIChief Financial Officer · Common StockOther 13 285 @ $1,10$15K · 2026-04-30
    • Zygmont Chester Stanley IIIChief Financial Officer · Common StockOther 13 100 @ $1,65$22K · 2026-02-04
    • CARVER JENNIFERDirector · Common StockOther 1 661 @ $1,87$3K · 2026-02-03
    • ROPER JESSDirector · Common StockOther 1 591 @ $1,85$3K · 2026-02-03
    • Chawla Lakhmir SDirector · Common StockOther 2 261 @ $1,85$4K · 2026-02-03
    • Rolke JamesDirector, Chief Executive Officer · Common StockOther 8 521 @ $1,86$16K · 2026-02-03
    • Rolke JamesDirector, Chief Executive Officer · Common StockOther 532 829 @ $0,90$480K · 2026-01-08
    • Zygmont Chester Stanley IIIChief Financial Officer · Common StockOther 78 145 @ $0,90$70K · 2026-01-08
    • CARVER JENNIFERDirector · Common StockOther 41 981 @ $0,90$38K · 2026-01-08
    • ROPER JESSDirector · Common StockOther 41 981 @ $0,90$38K · 2026-01-08
    • Chawla Lakhmir SDirector · Common StockOther 41 981 @ $0,90$38K · 2026-01-08
    • Chawla Lakhmir SDirector · Common StockOther 15 625 @ $1,28$20K · 2025-10-29
    • Rolke JamesDirector, Chief Executive Officer · Common StockOther 390 614 @ $1,28$500K · 2025-10-29
    • CARVER JENNIFERDirector · Common StockOther 15 625 @ $1,28$20K · 2025-10-29
    • Zygmont Chester Stanley IIIChief Financial Officer · Common StockOther 390 614 @ $1,28$500K · 2025-10-29
    • ROPER JESSDirector · Common StockOther 15 625 @ $1,28$20K · 2025-10-29

    Short positioning

    20.2Kshares short+44.9% vs prior
    1days to cover
    37.9%short of daily vol
    3.1Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    REVB.LCanonical
    London Stock Exchange · GBp

    Intel & risk

    PredictorM&A prob5 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 42.2%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 74.9%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 88.2%Derived (calculated)
    • Return on equity (FY 2025-12-31): -100.6%Derived (calculated)
    • Return on assets (FY 2025-12-31): -77.0%Derived (calculated)
    • Current ratio (FY 2025-12-31): 5.41xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.31xDerived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -13.7%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 14.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 64.6%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 54.9%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 40.7%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 97.7%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 97.7%Derived (calculated)
    • Shareholders' equity (annual): USD 8.86MSEC XBRL filing
    • Net income (annual): USD -8.91MSEC XBRL filing
    • Current assets (annual): USD 10.81MSEC XBRL filing
    • Shares outstanding (annual): 1.58MSEC XBRL filing
    • Operating cash flow (annual): USD -8.27MSEC XBRL filing
    • Total assets (annual): USD 11.58MSEC XBRL filing
    • Current liabilities (annual): USD 2MSEC XBRL filing
    • Operating income (annual): USD -9.07MSEC XBRL filing
    • R&D expense (annual): USD 4.06MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -24SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-28 03:14 UTCHOLDERInstitutional holding changed
    2026-06-28 03:14 UTCHOLDER1 institutional position change flagged
    2026-06-01FILING8-K filing →
    2026-05-11FILINGDEF 14A filing →
    2026-05-07FILING8-K filing →
    2026-05-07FILING10-Q filing →
    2026-04-30 00:00 UTCINSIDER2 insider transactions — 2026-04
    2026-04-30INSIDERRolke James transacted 10.1k sh — Director, Chief Executive Officer ~$11k
    2026-04-30INSIDERZygmont Chester Stanley III transacted 13.3k sh — Chief Financial Officer ~$15k
    2026-03-19FILING8-K filing →
    2026-02-26FILING8-K filing →
    2026-02-26FILING10-K filing →
    2026-02-17FILINGDEF 14A filing →
    2026-02-11FILING424B3 filing →
    2026-02-04 00:00 UTCINSIDER5 insider transactions — 2026-02
    2026-02-04INSIDERZygmont Chester Stanley III transacted 13.1k sh — Chief Financial Officer ~$22k
    2026-02-03INSIDERCARVER JENNIFER transacted 1.7k sh — Director ~$3k
    2026-02-03INSIDERROPER JESS transacted 1.6k sh — Director ~$3k
    2026-02-03INSIDERChawla Lakhmir S transacted 2.3k sh — Director ~$4k
    2026-02-03INSIDERRolke James transacted 8.5k sh — Director, Chief Executive Officer ~$16k
    2026-01-29FILING8-K filing →
    2026-01-22FILING8-K filing →
    2026-01-08 00:00 UTCINSIDER5 insider transactions — 2026-01 · net buy $663k
    2026-01-08INSIDERRolke James transacted 532.8k sh — Director, Chief Executive Officer ~$480k
    2026-01-08INSIDERZygmont Chester Stanley III transacted 78.1k sh — Chief Financial Officer ~$70k
    2026-01-08INSIDERCARVER JENNIFER transacted 42.0k sh — Director ~$38k
    2026-01-08INSIDERROPER JESS transacted 42.0k sh — Director ~$38k
    2026-01-08INSIDERChawla Lakhmir S transacted 42.0k sh — Director ~$38k
    2025-12-03FILING8-K filing →
    2025-10-29 00:00 UTCINSIDER5 insider transactions — 2025-10 · net buy $1.1M
    2025-10-29INSIDERChawla Lakhmir S transacted 15.6k sh — Director ~$20k
    2025-10-29INSIDERRolke James transacted 390.6k sh — Director, Chief Executive Officer ~$500k
    2025-10-29INSIDERCARVER JENNIFER transacted 15.6k sh — Director ~$20k
    2025-10-29INSIDERZygmont Chester Stanley III transacted 390.6k sh — Chief Financial Officer ~$500k
    2025-10-29INSIDERROPER JESS transacted 15.6k sh — Director ~$20k
    2025-08-22 07:01 UTCEARNINGSAnnual results — FY 2025 Revenue GBP 142.6M · Net GBP -17.2M
    2025-02-11 00:00 UTCINSIDER6 insider transactions — 2025-02 · net buy $178k
    2024-06-26 07:00 UTCEARNINGSAnnual results — FY 2024 Revenue GBP 191.3M · Net GBP 10.7M
    Showing the 40 most recent of 42 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage